OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Protective neutralizing epitopes in SARS‐CoV‐2
Hejun Liu, Ian A. Wilson
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 76-92
Open Access | Times Cited: 40
Hejun Liu, Ian A. Wilson
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 76-92
Open Access | Times Cited: 40
Showing 26-50 of 40 citing articles:
Site-directed neutralizing antibodies targeting structural sites on SARS-CoV-2 spike protein
Xiaofeng Li, Liudmila Kulakova, Kezzia S. Jones, et al.
New Biotechnology (2023) Vol. 80, pp. 27-36
Open Access | Times Cited: 2
Xiaofeng Li, Liudmila Kulakova, Kezzia S. Jones, et al.
New Biotechnology (2023) Vol. 80, pp. 27-36
Open Access | Times Cited: 2
Anti-SARS-CoV-2 Omicron BA.5 RBD antibody titers generated by the protein subunit vaccine Abdala in breast milk
Maylín Pérez-Bernal, Carlos Hernández-Suárez, Rafael Ibargollín, et al.
Vacunas (2024) Vol. 25, Iss. 3, pp. 331-339
Closed Access
Maylín Pérez-Bernal, Carlos Hernández-Suárez, Rafael Ibargollín, et al.
Vacunas (2024) Vol. 25, Iss. 3, pp. 331-339
Closed Access
Anti-SARS-CoV-2 Omicron BA.5 RBD antibody titers generated by the protein subunit vaccine Abdala in breast milk
Maylín Pérez-Bernal, Carlos Hernández-Suárez, Rafael Ibargollín, et al.
Vacunas (English Edition) (2024) Vol. 25, Iss. 3, pp. 331-339
Closed Access
Maylín Pérez-Bernal, Carlos Hernández-Suárez, Rafael Ibargollín, et al.
Vacunas (English Edition) (2024) Vol. 25, Iss. 3, pp. 331-339
Closed Access
Development of a two-component recombinant vaccine for COVID-19
Yisheng Sun, Fang Xu, Han-Ping Zhu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Yisheng Sun, Fang Xu, Han-Ping Zhu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
PdPANA: phagemid display as peptide array for neutralizing antibodies, an engineered in silico vaccine candidate against COVID-19
Javier Uzcátegui, Khaleel Mullah, Daniel Buvat de Virgini, et al.
Frontiers in Systems Biology (2024) Vol. 4
Open Access
Javier Uzcátegui, Khaleel Mullah, Daniel Buvat de Virgini, et al.
Frontiers in Systems Biology (2024) Vol. 4
Open Access
Longitudinal profiling of B cells primed by mRNA vaccine and recalled by Omicron variants uncovers antibodies broadly neutralizing sarbecoviruses
Xixian Chen, Ling Li, Ruiping Du, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Xixian Chen, Ling Li, Ruiping Du, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Altered spike dynamics drives immune evasion of SARS-CoV-2
Kalle Saksela, Hasan Uğurlu, Petja Salminen, et al.
Research Square (Research Square) (2024)
Closed Access
Kalle Saksela, Hasan Uğurlu, Petja Salminen, et al.
Research Square (Research Square) (2024)
Closed Access
Coronaviruses: Pandemic SARS-CoV-2
Benjamin J. Cowling, Sook‐San Wong
Springer eBooks (2024), pp. 1-79
Closed Access
Benjamin J. Cowling, Sook‐San Wong
Springer eBooks (2024), pp. 1-79
Closed Access
Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody to antigenically distinct omicron SARS-CoV-2 subvariants
Siriruk Changrob, Peter Halfmann, Hejun Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Siriruk Changrob, Peter Halfmann, Hejun Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Defining neutralization and allostery by antibodies against COVID-19 variants
Nikhil Kumar Tulsian, Palur Venkata Raghuvamsi, Xinlei Qian, et al.
Research Square (Research Square) (2023)
Open Access
Nikhil Kumar Tulsian, Palur Venkata Raghuvamsi, Xinlei Qian, et al.
Research Square (Research Square) (2023)
Open Access
Breakthrough infection elicits hypermutated IGHV3-53/3-66 public antibodies with broad and potent neutralizing activity against SARS-CoV-2 variants including BQ and XBB lineages
Ling Li, Xixian Chen, Zuowei Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Ling Li, Xixian Chen, Zuowei Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
The variable conversion of neutralizing anti-SARS-CoV-2 single-chain antibodies to IgG provides insight into RBD epitope accessibility
Matthew Chang, Hanzhong Ke, Laura Losada Miguéns, et al.
Protein Engineering Design and Selection (2023) Vol. 36
Open Access
Matthew Chang, Hanzhong Ke, Laura Losada Miguéns, et al.
Protein Engineering Design and Selection (2023) Vol. 36
Open Access
SARS-CoV-2 Spike protein peptides displayed in the Pyrococcus furiosus RAD system preserve epitopes antigenicity, immunogenicity, and virus-neutralizing activity of antibodies
Victor Bolsanelli Cioffi, Maria Fernanda de Castro‐Amarante, Aleksei Lulla, et al.
Research Square (Research Square) (2023)
Open Access
Victor Bolsanelli Cioffi, Maria Fernanda de Castro‐Amarante, Aleksei Lulla, et al.
Research Square (Research Square) (2023)
Open Access
Evidence of antigenic drift in the fusion machinery core of SARS-CoV-2 spike
Timothy J.C. Tan, Abby Odle, Ruipeng Lei, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Timothy J.C. Tan, Abby Odle, Ruipeng Lei, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Introductory article for Immunological Reviews, Vol 310
Dennis R. Burton, Mark B. Feinberg
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 4-5
Closed Access
Dennis R. Burton, Mark B. Feinberg
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 4-5
Closed Access
